Evandro de Azambuja

Research interests

Publications

• Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

  The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)00285-4

• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

  European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac244

• Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2105215

• EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.07.016

• ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.09.019

• Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.01204

• Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00288-6

• Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2019.10.023

• Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1703643

• 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(16)32616-2

• EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

  Annals of Oncology · 2017 · 10.1093/annonc/mdx221

• Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

  Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv106

• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.62.1797

• Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.54.1870

• Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2011.41.0902

• Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis

  Breast Cancer Research and Treatment · 2013 · https://doi.org/10.1007/s10549-013-2525-y

• Dissecting the Heterogeneity of Triple-Negative Breast Cancer

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.2010

• Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

  The Lancet · 2012 · 10.1016/s0140-6736(11)61847-3

• Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

  British Journal of Cancer · 2007 · https://doi.org/10.1038/sj.bjc.6603756

Current projects

No projects listed.